CRON Stock Overview
Operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CRON from our risk checks.
Cronos Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$3.80 |
| 52 Week High | CA$4.28 |
| 52 Week Low | CA$2.15 |
| Beta | 1.08 |
| 1 Month Change | 18.01% |
| 3 Month Change | 27.09% |
| 1 Year Change | 49.61% |
| 3 Year Change | -59.70% |
| 5 Year Change | -81.51% |
| Change since IPO | 357.83% |
Recent News & Updates
Recent updates
Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce
Apr 01
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth
Mar 02Revenues Tell The Story For Cronos Group Inc. (TSE:CRON)
Feb 02Companies Like Cronos Group (TSE:CRON) Are In A Position To Invest In Growth
Nov 09We're Hopeful That Cronos Group (TSE:CRON) Will Use Its Cash Wisely
Jul 17Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors
Jun 20We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth
Feb 09A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)
Oct 12We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate
Sep 10Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Aug 12We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth
May 19Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?
Jul 29An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued
Apr 08Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently?
Mar 04What You Need To Know About Cronos Group Inc.'s (TSE:CRON) Investor Composition
Jan 22
Does Cronos Group's (TSE:CRON) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 18Shareholder Returns
| CRON | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -3.8% | -5.6% | 0.3% |
| 1Y | 49.6% | 50.3% | 12.5% |
Return vs Industry: CRON matched the Canadian Pharmaceuticals industry which returned 50.3% over the past year.
Return vs Market: CRON exceeded the Canadian Market which returned 12.5% over the past year.
Price Volatility
| CRON volatility | |
|---|---|
| CRON Average Weekly Movement | 9.1% |
| Pharmaceuticals Industry Average Movement | 14.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 17.9% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CRON's share price has been volatile over the past 3 months.
Volatility Over Time: CRON's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 356 | Mike Gorenstein | www.thecronosgroup.com |
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Cronos Group Inc. Fundamentals Summary
| CRON fundamental statistics | |
|---|---|
| Market cap | CA$1.45b |
| Earnings (TTM) | -CA$74.12m |
| Revenue (TTM) | CA$127.36m |
11.4x
P/S Ratio-19.6x
P/E RatioIs CRON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRON income statement (TTM) | |
|---|---|
| Revenue | US$93.03m |
| Cost of Revenue | US$79.57m |
| Gross Profit | US$13.47m |
| Other Expenses | US$67.61m |
| Earnings | -US$54.14m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 14.47% |
| Net Profit Margin | -58.20% |
| Debt/Equity Ratio | 0% |
How did CRON perform over the long term?
See historical performance and comparison